Paper
A Role of PPAR-γ in Androstenediol-Mediated Salutary Effects on Cardiac Function Following Trauma-Hemorrhage
Published Jul 1, 2006 · Tomoharu Shimizu, L. Szalay, Y. Hsieh
Annals of Surgery
22
Citations
1
Influential Citations
Abstract
Objective:To examine the mechanism by which androstenediol improves cardiac function following trauma-hemorrhage (T-H). Summary Background Data:Androstenediol administration improves cardiovascular function and attenuates proinflammatory cytokine production following T-H. Activation of the peroxisome proliferator-activated receptor-gamma (PPAR-γ) has been shown to be protective following ischemic conditions. We hypothesized that PPAR-γ activation plays a role in the androstenediol-mediated salutary effects on cardiac function following T-H. Methods:Male rats underwent laparotomy and hemorrhagic shock (40 mm Hg for 90 minutes), followed by resuscitation with 4 times the shed blood volume in the form of Ringer's lactate. Androstenediol (1 mg/kg body weight, i.v.) was administrated at the end of resuscitation. In a separate group of animals, a PPAR-γ antagonist (GW9662) was administered simultaneously with androstenediol and animals were killed at 5 hours thereafter. Results:A decrease in cardiac function and an increase in IL-6 and iNOS gene expression were observed following T-H. Androstenediol treatment normalized cardiac function, increased PPAR-γ DNA binding activity, attenuated IL-6 and iNOS gene expressions, and reduced plasma IL-6. Plasma 15-deoxy-Δ12, 14-prostaglandin J2 (PGJ2, an endogenous PPAR-γ agonist) levels were also increased in androstenediol-treated T-H rats, but these levels were lower than those observed in shams. Coadministration of PPAR-γ antagonist along with androstenediol, however, prevented the androstenediol-mediated reduction in cardiac iNOS and IL-6 expressions and abolished the improvements in cardiac function. Conclusion:The androstenediol-mediated salutary effects on cardiac function following T-H appear to be mediated at least in part via PPAR-γ activation, which down-regulates IL-6 and iNOS gene expression in the heart.
Androstenediol improves cardiac function after trauma-hemorrhage by activating PPAR-, which down-regulates IL-6 and iNOS gene expression in the heart.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...